Darin Ostrander

Research output

Research output per year 2011 2021 2023 2023

• 36 Article
• 1 Comment/debate

Research output per year

Research output per year

Search results

• 2023

  Coronavirus Disease 2019–Associated Pulmonary Aspergillosis: A Noninvasive Screening Model for Additional Diagnostics

  Permpalung, N., Chiang, T. P. Y., Avery, R. K., Ostrander, D., Datta, K., Segev, D. L., Durand, C. M., Zhang, S. X., Massie, A. B. & Marr, K. A., Apr 1 2023, In: Open Forum Infectious Diseases. 10, 4, ofad155.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Pulmonary Aspergillosis 100%
  • Coronavirus 87%
  • Area Under Curve 12%
  • Hematologic Neoplasms 7%
  • Multiple Myeloma 7%

• Efficacy of ceftazidime-avibactam in solid organ transplant recipients with bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae

  REIPI/INCREMENT-SOT Study Group, Jul 2023, In: American Journal of Transplantation. 23, 7, p. 1022-1034 13 p.

  Research output: Contribution to journal › Article › peer-review

  • ceftazidime drug combination avibactam 100%
  • carbapenemase 80%
  • Klebsiella pneumoniae 63%
  • Transplant Recipients 55%
  • Transplants 37%

• HIV-Positive Liver Transplant Does not Alter the Latent Viral Reservoir in Recipients With Antiretroviral Therapy-Suppressed HIV

  Benner, S. E., Zhu, X., Hussain, S., Florman, S., Eby, Y., Fernandez, R. E., Ostrander, D., Rana, M., Ottmann, S., Hand, J., Price, J. C., Pereira, M. R., Wojciechowski, D., Simkins, J., Stosor, V., Mehta, S. A., Aslam, S., Malinis, M., Haidar, G., Massie, A., & 11 othersSmith, M. L., Odim, J., Morsheimer, M., Quinn, T. C., Laird, G. M., Siliciano, R., Balagopal, A., Segev, D. L., Durand, C. M., Redd, A. D. & Tobian, A. A. R., Nov 1 2023, In: Journal of Infectious Diseases. 228, 9, p. 1274-1279 6 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Proviruses 100%
  • Liver Transplantation 93%
  • HIV 70%
  • Liver 26%
  • HIV-1 22%

• Invasive fungal infections after respiratory viral infections in lung transplant recipients are associated with lung allograft failure and chronic lung allograft dysfunction within 1 year

  Permpalung, N., Liang, T., Gopinath, S., Bazemore, K., Mathew, J., Ostrander, D., Durand, C. M., Shoham, S., Zhang, S. X., Marr, K. A., Avery, R. K. & Shah, P. D., Jul 2023, In: Journal of Heart and Lung Transplantation. 42, 7, p. 953-963 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Invasive Fungal Infections 100%
  • Respiratory Tract Infections 71%
  • Transplant Recipients 71%
  • Allografts 67%
  • Virus Diseases 56%

• Progressive disseminated histoplasmosis: The experience in one non-endemic medical center

  Li, L. X., Rajack, S. T. A., Ostrander, D., Datta, K., Totten, M., Avery, R. K., Zhang, S. X., Marr, K. & Permpalung, N., Dec 1 2023, In: Medical mycology. 61, 12, myad115.

  Research output: Contribution to journal › Article › peer-review

  • Histoplasmosis 100%
  • Length of Stay 8%
  • Preexisting Condition Coverage 6%
  • Amphotericin B 5%
  • North America 5%
• 2022

  Coronavirus Disease 2019-Associated Pulmonary Aspergillosis in Mechanically Ventilated Patients

  Permpalung, N., Chiang, T. P. Y., Massie, A. B., Zhang, S. X., Avery, R. K., Nematollahi, S., Ostrander, D., Segev, D. L. & Marr, K. A., Jan 1 2022, In: Clinical Infectious Diseases. 74, 1, p. 83-91 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Pulmonary Aspergillosis 100%
  • Coronavirus 87%
  • Multiple Myeloma 7%
  • Vascular Diseases 7%
  • Critical Illness 7%

• HOPE in action: A prospective multicenter pilot study of liver transplantation from donors with HIV to recipients with HIV

  the HOPE in Action Investigators, Mar 2022, In: American Journal of Transplantation. 22, 3, p. 853-864 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Liver Transplantation 100%
  • Multicenter Studies 95%
  • Tissue Donors 86%
  • HIV 75%
  • Graft Survival 24%

• The effect of induction immunosuppression for kidney transplant on the latent HIV reservoir

  Benner, S. E., Eby, Y., Zhu, X., Fernandez, R. E., Patel, E. U., Ruff, J. E., Habtehyimer, F., Schmidt, H. A., Kirby, C. S., Hussain, S., Ostrander, D., Desai, N. M., Florman, S., Rana, M. M., Friedman-Moraco, R., Pereira, M. R., Mehta, S., Stock, P., Gilbert, A., Morris, M. I., & 21 othersStosor, V., Mehta, S. A., Small, C. B., Ranganna, K., Santos, C. A. Q., Aslam, S., Husson, J., Malinis, M., Elias, N., Blumberg, E. A., Doby, B. L., Massie, A. B., Smith, M. L., Odim, J., Quinn, T. C., Laird, G. M., Siliciano, R. F., Segev, D. L., Redd, A. D., Durand, C. M. & Tobian, A. A. R., Nov 8 2022, In: JCI Insight. 7, 21, e162968.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Immunosuppression 100%
  • Lymphocytes 76%
  • HIV 76%
  • Transplants 69%
  • Kidney 59%
• 2021

  A prospective multicenter pilot study of HIV-positive deceased donor to HIV-positive recipient kidney transplantation: HOPE in action

  the HOPE in Action Investigators, May 2021, In: American Journal of Transplantation. 21, 5, p. 1754-1764 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Kidney Transplantation 100%
  • Multicenter Studies 91%
  • HIV 72%
  • aliflurane 9%
  • Opportunistic Infections 7%
  2 Scopus citations

• Efficacy of β-lactam/β-lactamase inhibitors to treat extended-spectrum beta-lactamase-producing Enterobacterales bacteremia secondary to urinary tract infection in kidney transplant recipients (INCREMENT-SOT Project)

  Investigators from the REIPI/INCREMENT-SOT Group & Swiss Transplant Cohort Study (STCS), Jun 2021, In: Transplant Infectious Disease. 23, 3, e13520.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Lactams 100%
  • beta-Lactamases 75%
  • Bacteremia 71%
  • Urinary Tract Infections 66%
  • Transplant Recipients 65%

• Inpatient COVID-19 outcomes in solid organ transplant recipients compared to non-solid organ transplant patients: A retrospective cohort

  Avery, R. K., Chiang, T. P. Y., Marr, K. A., Brennan, D. C., Sait, A. S., Garibaldi, B. T., Shah, P., Ostrander, D., Steinke, S. M., Permpalung, N., Cochran, W., Makary, M. A., Garonzik-Wang, J., Segev, D. L. & Massie, A. B., Jul 2021, In: American Journal of Transplantation. 21, 7, p. 2498-2508 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Transplant Recipients 100%
  • Inpatients 86%
  • Transplants 67%
  • Length of Stay 18%
  • SARS Virus 12%
  6 Scopus citations

• Letermovir treatment of cytomegalovirus infection or disease in solid organ and hematopoietic cell transplant recipients

  Linder, K. A., Kovacs, C., Mullane, K. M., Wolfe, C., Clark, N. M., La Hoz, R. M., Smith, J., Kotton, C. N., Limaye, A. P., Malinis, M., Hakki, M., Mishkin, A., Gonzalez, A. A., Prono, M. D., Ostrander, D., Avery, R. & Kaul, D. R., Aug 2021, In: Transplant Infectious Disease. 23, 4, e13687.

  Research output: Contribution to journal › Article › peer-review

  • AIC246 100%
  • Cytomegalovirus Infections 58%
  • Transplant Recipients 49%
  • Transplants 33%
  • Viral Load 25%

• Outcomes of SOT Recipients with COVID-19 in Different Eras of COVID-19 Therapeutics

  Sait, A. S., Chiang, T. P. Y., Marr, K. A., Massie, A. B., Cochran, W., Shah, P., Brennan, D. C., Thomas, A. G., Mehta Steinke, S., Permpalung, N., Shoham, S., Merlo, C., Jain, T., Boyarsky, B., Charnaya, O., Gurakar, A., Sharma, K., Durand, C. M., Werbel, W. A., Huang, C. Y., & 9 othersOstrander, D., Desai, N., Kim, M. Y., Alasfar, S., Bloch, E. M., Tobian, A. A. R., Garonzik-Wang, J., Segev, D. L. & Avery, R. K., Dec 23 2021, In: Transplantation Direct. 8, 1, p. E1268

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • GS-5734 100%
  • Coronavirus 73%
  • Dexamethasone 43%
  • Transplants 29%
  • Inpatients 28%

• Outcomes of transplant recipients treated with cidofovir for resistant or refractory cytomegalovirus infection

  Mehta Steinke, S. A., Alfares, M., Valsamakis, A., Shoham, S., Arav-Boger, R., Lees, L., Ostrander, D., Forman, M. S., Shedeck, A., Ambinder, R. F., Jones, R. J. & Avery, R. K., Jun 2021, In: Transplant Infectious Disease. 23, 3, e13521.

  Research output: Contribution to journal › Article › peer-review

  • Cidofovir 100%
  • Cytomegalovirus Infections 75%
  • Transplant Recipients 63%
  • Cytomegalovirus 53%
  • Transplants 42%

• Propensity score and desirability of outcome ranking analysis of ertapenem for treatment of nonsevere bacteremic urinary tract infections due to extended-spectrum-beta-lactamase-producing enterobacterales in kidney transplant recipients

  the REIPI/ESGICH/ESGBIS/INCREMENT-SOT Group, Nov 2021, In: Antimicrobial agents and chemotherapy. 65, 11, e01102-21.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Ertapenem 100%
  • Meropenem 82%
  • Propensity Score 72%
  • beta-Lactamases 72%
  • Urinary Tract Infections 64%

• Quantifying infection risks in incompatible living donor kidney transplant recipients

  Avery, R. K., Motter, J. D., Jackson, K. R., Montgomery, R. A., Massie, A. B., Kraus, E. S., Marr, K. A., Lonze, B. E., Alachkar, N., Holechek, M. J., Ostrander, D., Desai, N., Waldram, M. M., Shoham, S., Steinke, S. M., Subramanian, A., Hiller, J. M., Langlee, J., Young, S., Segev, D. L., & 1 othersGaronzik Wang, J. M., Apr 2021, In: American Journal of Transplantation. 21, 4, p. 1564-1575 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Living Donors 100%
  • Transplant Recipients 82%
  • Kidney Transplantation 48%
  • Kidney 47%
  • Infections 42%
  1 Scopus citations

• Utility of Serial Donor-derived Cell-free DNA Measurements for Detecting Allograft Rejection in a Kidney Transplant Recipient After PD-1 Checkpoint Inhibitor Administration

  Lakhani, L., Alasfar, S., Bhalla, A., Aala, A., Rosenberg, A., Ostrander, D., Schollenberger, M. D., Brennan, D. C. & Lipson, E. J., Jan 15 2021, In: Transplantation Direct. 7, 2, p. E656

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Cell-Free Nucleic Acids 100%
  • Transplant Recipients 73%
  • Allografts 69%
  • Tissue Donors 62%
  • pembrolizumab 47%
• 2020

  A multicenter, longitudinal cohort study of cryptococcosis in human immunodeficiency virus-negative people in the United States

  Marr, K. A., Sun, Y., Spec, A., Lu, N., Panackal, A., Bennett, J., Pappas, P., Ostrander, D., Datta, K., Zhang, S. X. & Williamson, P. R., Jan 15 2020, In: Clinical Infectious Diseases. 70, 2, p. 252-261 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Cryptococcosis 100%
  • Longitudinal Studies 63%
  • Mental Status and Dementia Tests 53%
  • HIV 52%
  • Cohort Studies 52%
  17 Scopus citations

• Brief Report: Willingness to Accept HIV-Infected and Increased Infectious Risk Donor Organs Among Transplant Candidates Living With HIV

  Seaman, S. M., Van Pilsum Rasmussen, S. E., Nguyen, A. Q., Halpern, S. E., You, S., Waldram, M. M., Anjum, S. K., Bowring, M. G., Muzaale, A. D., Ostrander, D. B., Brown, D., Massie, A. B., Tobian, A. A. R., Henderson, M. L., Fletcher, F. E., Smith, B., Chao, A., Gorupati, N., Prakash, K., Aslam, S., & 10 othersLee, D. H., Kirchner, V., Pruett, T. L., Haidar, G., Hughes, K., Malinis, M., Trinh, S., Segev, D. L., Sugarman, J. & Durand, C. M., Sep 1 2020, In: Journal of Acquired Immune Deficiency Syndromes. 85, 1, p. 88-92 5 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Tissue Donors 100%
  • HIV 87%
  • Transplants 79%
  • Transplantation 32%
  • Superinfection 6%
  3 Scopus citations

• Predictors of mortality in solid organ transplant recipients with bloodstream infections due to carbapenemase-producing Enterobacterales: The impact of cytomegalovirus disease and lymphopenia

  REIPI/INCREMENT-SOT Investigators, Jun 1 2020, In: American Journal of Transplantation. 20, 6, p. 1629-1641 13 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • carbapenemase 100%
  • Lymphopenia 91%
  • Cytomegalovirus 74%
  • Transplant Recipients 69%
  • Transplants 46%
  3 Scopus citations

• The Impact of COVID-19 on the State of Clinical and Laboratory Research Globally in Transplantation in May 2020

  Bromberg, J., Baan, C., Chapman, J., Anegon, I., Brennan, D. C., Chakera, A., Chong, A. S., Geissler, E. K., Guillonneau, C., Heaton, N., Hesselink, D. A., Jassem, W., Jones, C. M., Josien, R., Kaplan, B., Kaufman, C. L., Lim, W., Ma, Y., Massey, E., Ostrander, D. B., & 4 othersSlaughter, M. S., Tullius, S., Witkowski, P. & Wong, G., Nov 1 2020, In: Transplantation. 104, 11, p. 2252-2257 6 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  3 Scopus citations
• 2018

  Direct-acting antiviral prophylaxis in kidney transplantation from hepatitis C virus-infected donors to noninfected recipients an open-label nonrandomized trial

  Durand, C. M., Bowring, M. G., Brown, D. M., Chattergoon, M. A., Massaccesi, G., Bair, N., Wesson, R., Reyad, A., Naqvi, F. F., Ostrander, D., Sugarman, J., Segev, D. L., Sulkowski, M. & Desai, N. M., Apr 17 2018, In: Annals of internal medicine. 168, 8, p. 523-540 18 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Kidney Transplantation 100%
  • Hepacivirus 97%
  • Antiviral Agents 90%
  • Tissue Donors 82%
  • 2-(pyrrolidin-2-yl)-5-(2-(4-(5-(pyrrolidin-2-yl)-1H-imidazol-2-yl)phenyl)benzofuran-5-yl)-1H-imidazole 57%
  142 Scopus citations

• Organs from deceased donors with false-positive HIV screening tests: An unexpected benefit of the HOPE act

  Durand, C. M., Halpern, S. E., Bowring, M. G., Bismut, G. A., Kusemiju, O. T., Doby, B., Fernandez, R. E., Kirby, C. S., Ostrander, D., Stock, P. G., Mehta, S., Turgeon, N. A., Wojciechowski, D., Huprikar, S., Florman, S., Ottmann, S., Desai, N. M., Cameron, A., Massie, A. B., Tobian, A. A. R., & 2 othersRedd, A. D. & Segev, D. L., Oct 2018, In: American Journal of Transplantation. 18, 10, p. 2579-2586 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Tissue Donors 100%
  • HIV 87%
  • HIV Antibodies 41%
  • Nucleic Acids 31%
  • Organ Transplantation 22%
  13 Scopus citations

• Urine Antigen Detection as an Aid to Diagnose Invasive Aspergillosis

  Marr, K. A., Datta, K., Mehta, S., Ostrander, D. B., Rock, M., Francis, J. & Feldmesser, M., Nov 13 2018, In: Clinical Infectious Diseases. 67, 11, p. 1712-1719 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Aspergillosis 100%
  • Urine 59%
  • Antigens 53%
  • Confidence Intervals 50%
  • galactomannan 35%
  22 Scopus citations
• 2017

  Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study

  IRC002 Study Team, Jun 2017, In: The Lancet Respiratory Medicine. 5, 6, p. 500-511 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Human Influenza 100%
  • Standard of Care 23%
  • National Institute of Allergy and Infectious Diseases (U.S.) 18%
  • Therapeutics 17%
  • Tachypnea 15%
  59 Scopus citations

• Unique characteristics of cryptococcosis identified after death in patients with liver cirrhosis: comparison with concurrent cohort diagnosed antemortem

  Singh, N., Sifri, C. D., Silveira, F. P., Miller, R., Gregg, K. S., Huprikar, S., Lease, E. D., Zimmer, A., Dummer, J. S., Spak, C. W., Koval, C., Banach, D. B., Shroff, M., Le, J., Ostrander, D., Avery, R., Eid, A., Razonable, R. R., Montero, J., Blumberg, E., & 8 othersAlynbiawi, A., Morris, M. I., Randall, H. B., Alangaden, G., Tessier, J., Cacciarelli, T. V., Wagener, M. M. & Sun, H. Y., Apr 1 2017, In: Medical mycology. 55, 3, p. 278-284 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Cryptococcosis 100%
  • Liver Cirrhosis 71%
  • Antigens 24%
  • Fibrosis 18%
  • Fungemia 18%
  3 Scopus citations
• 2016

  False-positive hepatitis C virus serology after placement of a ventricular assistance device

  Durand, C. M., Marr, K. A., Ostrander, D., Subramanian, A., Valsamakis, A., Cox, A. & Neofytos, D., Feb 1 2016, In: Transplant Infectious Disease. 18, 1, p. 146-149 4 p.

  Research output: Contribution to journal › Article › peer-review

  • Heart-Assist Devices 100%
  • Hepatitis C Antibodies 89%
  • Serology 89%
  • Hepacivirus 78%
  • Equipment and Supplies 50%
  6 Scopus citations

• Outcomes in Transplant Recipients Treated with Foscarnet for Ganciclovir-Resistant or Refractory Cytomegalovirus Infection

  Avery, R. K., Arav-Boger, R., Marr, K. A., Kraus, E., Shoham, S., Lees, L., Trollinger, B., Shah, P., Ambinder, R., Neofytos, D., Ostrander, D., Forman, M. & Valsamakis, A., Oct 1 2016, In: Transplantation. 100, 10, p. e74-e80

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Foscarnet 100%
  • Ganciclovir 86%
  • Cytomegalovirus Infections 77%
  • Transplant Recipients 64%
  • Transplants 43%
  51 Scopus citations
• 2015

  Cryptococcosis in patients with cirrhosis of the liver and posttransplant outcomes

  Singh, N., Sifri, C. D., Silveira, F. P., Miller, R., Gregg, K. S., Huprikar, S., Lease, E. D., Zimmer, A., Stephen Dummer, J., Spak, C. W., Koval, C., Banach, D. B., Shroff, M., Le, J., Ostrander, D., Avery, R., Eid, A., Razonable, R. R., Montero, J., Blumberg, E., & 7 othersAlynbiawi, A., Morris, M. I., Randall, H. B., Alangaden, G., Tessier, J., Wagener, M. M. & Sun, H. Y., 2015, In: Transplantation. 99, 10, p. 2132-2141 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Cryptococcosis 100%
  • Liver Cirrhosis 71%
  • Transplantation 46%
  • Liver Transplantation 27%
  • Fibrosis 22%
  16 Scopus citations

• Posaconazole liquid suspension in solid organ transplant recipients previously treated with voriconazole

  Shoham, S., Ostrander, D. & Marr, K., Jun 1 2015, In: Transplant Infectious Disease. 17, 3, p. 493-496 4 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • posaconazole 100%
  • Voriconazole 89%
  • Transplant Recipients 65%
  • Suspensions 61%
  • Transplants 44%
  6 Scopus citations

• Voriconazole therapeutic drug monitoring: Results of a prematurely discontinued randomized multicenter trial

  Neofytos, D., Ostrander, D., Shoham, S., Laverdiere, M., Hiemenz, J., Nguyen, H., Clarke, W., Brass, L., Lu, N. & Marr, K. A., Dec 1 2015, In: Transplant Infectious Disease. 17, 6, p. 831-837 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Voriconazole 100%
  • Drug Monitoring 90%
  • Multicenter Studies 68%
  • Treatment Failure 9%
  • Pharmaceutical Preparations 8%
  9 Scopus citations
• 2013

  Epidemiology, outcomes, and mortality predictors of invasive mold infections among transplant recipients: A 10-year, single-center experience

  Neofytos, D., Treadway, S., Ostrander, D., Alonso, C. D., Dierberg, K. L., Nussenblatt, V., Durand, C. M., Thompson, C. B. & Marr, K. A., Jun 2013, In: Transplant Infectious Disease. 15, 3, p. 233-242 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • antineoplaston A10 100%
  • Transplant Recipients 75%
  • Fungi 73%
  • Epidemiology 64%
  • Transplants 50%
  93 Scopus citations

• Epidemiology, outcomes, and risk factors of invasive fungal infections in adult patients with acute myelogenous leukemia after induction chemotherapy

  Neofytos, D., Lu, K., Hatfield-Seung, A., Blackford, A., Marr, K. A., Treadway, S., Ostrander, D., Nussenblatt, V. & Karp, J., Feb 2013, In: Diagnostic Microbiology and Infectious Disease. 75, 2, p. 144-149 6 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Invasive Fungal Infections 100%
  • Induction Chemotherapy 92%
  • Acute Myeloid Leukemia 73%
  • Epidemiology 60%
  • Invasive Candidiasis 44%
  48 Scopus citations

• Epidemiology, risk factors, and outcomes of Clostridium difficile infection in kidney transplant recipients

  Neofytos, D., Kobayashi, K., Alonso, C. D., Cady-Reh, J., Lepley, D., Harris, M., Desai, N., Kraus, E., Subramanian, A., Treadway, S., Ostrander, D., Thompson, C. & Marr, K., Apr 2013, In: Transplant Infectious Disease. 15, 2, p. 134-141 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Clostridium Infections 100%
  • Transplant Recipients 74%
  • Epidemiology 62%
  • Kidney 42%
  • Transplants 22%
  30 Scopus citations

• Histoplasmosis after solid organ transplant

  Assi, M., Martin, S., Wheat, L. J., Hage, C., Freifeld, A., Avery, R., Baddley, J. W., Vergidis, P., Miller, R., Andes, D., Young, J. A. H., Hammoud, K., Huprikar, S., McKinsey, D., Myint, T., Garcia-Diaz, J., Esguerra, E., Kwak, E. J., Morris, M., Mullane, K. M., & 7 othersPrakash, V., Burdette, S. D., Sandid, M., Dickter, J., Ostrander, D., Antoun, S. A. & Kaul, D. R., Dec 1 2013, In: Clinical Infectious Diseases. 57, 11, p. 1542-1549 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Histoplasmosis 100%
  • Transplants 46%
  • Azoles 31%
  • Amphotericin B 27%
  • Pancreas 21%
  84 Scopus citations
• 2012

  Administration of voriconazole in patients with renal dysfunction

  Neofytos, D., Lombardi, L. R., Shields, R. K., Ostrander, D., Warren, L., Nguyen, M. H., Thompson, C. B. & Marr, K. A., Apr 1 2012, In: Clinical Infectious Diseases. 54, 7, p. 913-921 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Voriconazole 100%
  • Kidney 42%
  • Creatinine 34%
  • Odds Ratio 33%
  • Penicillins 26%
  43 Scopus citations
• 2011

  The growing role of clinical and genomic databases in the development of antifungal strategies

  Shoham, S. & Ostrander, D. B., Dec 2011, In: Current Fungal Infection Reports. 5, 4, p. 190-192 3 p.

  Research output: Contribution to journal › Comment/debate › peer-review

  • Antifungal Agents 100%
  • Clinical Trials 55%
  • Invasive Fungal Infections 55%
  • Databases 51%
  • Hematopoietic Stem Cell Transplantation 45%